SCHEMBL23767359

SCHEMBL23767359

CCCCCN(C)CCN(C)CCN(C)CCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.58
S1PR2 O95136 1/20 0.54
S1PR1 P21453 1/20 0.54
S1PR3 Q99500 1/20 0.54
S1PR5 Q9H228 1/20 0.54
GGPS1 O95749 4/20 0.48
FDPS P14324 1/20 0.48
AGTR1 P30556 1/20 0.48
OPRM1 P35372 1/20 0.48
PDE3A Q14432 1/20 0.48
CHRM2 P08172 1/20 0.48
KDM5A P29375 3/20 0.45
KDM4C Q9H3R0 2/20 0.45
KDM5C P41229 1/20 0.45
KDM5B Q9UGL1 1/20 0.45
CA12 O43570 1/20 0.44
CA2 P00918 1/20 0.44
CA3 P07451 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29581487 1.00 DNM1 (0.58) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL23767401 1.00 DNM1 (0.58) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL9616951 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL29581354 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL30463703 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL3196734 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL29581357 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL16710945 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL4827816 0.97 DNM1 (0.63) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL16790931 0.97 DNM1 (0.61) DNM1S1PR2S1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028445-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS EVONIK OPERATIONS GMBH (DE) 2026-01-29 US claimed
US-20220144996-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS EVONIK OPERATIONS GMBH (DE) 2022-05-12 US claimed
US-20260028445-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS EVONIK OPERATIONS GMBH (DE) 2026-01-29 US disclosed
US-20220144996-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS EVONIK OPERATIONS GMBH (DE) 2022-05-12 US disclosed
WO-2021163339-A1 CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS GENEVANT SCIENCES GMBH (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028445-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS RFC2, RFC3, PUF60 DNM1 3215/4885S1PR2 3530/4885S1PR1 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.